You are here

Medical Testing

Paxlovid slashed risk of COVID hospital stay in unvaccinated patients -- Canadian study

The antiviral drug Paxlovid was tied to a 96% lower relative risk (RR) of COVID-19 hospitalization among high-risk outpatients who didn't complete a primary vaccination series but didn't benefit those who had received at least two doses amid the SARS-CoV-2 Omicron variant, according to a real-world study published yesterday in Clinical Infectious Diseases.

....

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Overview of how the end of the national Covid emergency will affect Americans

...

As this long emergency period expires, experts say, the biggest impact for consumers will be the end of free coronavirus tests — both at-home tests and those performed by clinicians and analyzed by commercial labs — with broad implications for people’s ability to get timely covid diagnoses, prevent disease transmission and track the virus.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Bivalent COVID vaccine shows good Omicron protection while older version wanes --studies

Two studies published today measure the vaccine effectiveness (VE) of COVID-19 vaccines against laboratory-confirmed Omicron variant and subvariants and symptomatic disease. Vaccines that target the newer variants performed well, but primary vaccines offered rapidly waning protection from SARS-CoV-2 infections in the post-Omicron era.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Medical Testing
howdy folks
Page loaded in 1.748 seconds.